We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Multiplex Nucleic Acid Suspension Bead Array Detects Filoviruses

By LabMedica International staff writers
Posted on 28 Apr 2015
Filoviruses (FVs) are ribonucleic acid (RNA) viruses that belong to the family Filoviridae, which includes zoonotic pathogens of the three genera Ebolavirus (EV), Marburgvirus (MV), and Cuevavirus (CV).

Multiplex suspension bead array systems that allow fast and reliable detection of reverse transcriptase polymerase chain reaction (RT-PCR) amplified filovirus genomes and enabled subtyping of Ebolavirus species and Marburgvirus strains has been described. More...


Scientists at the Public Health Agency of Sweden (Solna, Sweden) and their colleagues set up a multiplex suspension bead array system, by designing two different RT-PCRs that could amplify all known EV and MV species, respectively, based on whole-genome sequences of FVs, including Reston ebolavirus (RESTV), and Bundibugyo ebolavirus (BDBV). The RT-PCRs were performed using a SuperScript III One-Step RT-PCR kit with Platinum Taq (Invitrogen, Carlsbad CA, USA).

The RT-PCR amplicons were also sequenced to confirm specificity. In parallel, different sets of magnetic Bio-Plex Pro COOH beads (Bio-Rad Laboratories, Hercules, CA, USA) were coupled with oligonucleotides specific for each EV species and MV strain. The suspension bead arrays were also tested on human sera spiked with Lassa virus, Dengue virus serotypes 1 to 4, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, and 10 FV-negative human sera. The results did not reveal any cross-reactivity which demonstrated the utility of the microsphere-based assay as a rapid and accurate diagnostic tool for confirming suspected FV infections.

The EV system can distinguish between three EV species and the MV system can distinguish between four MV strains. Based on the sequence information from the current Ebola outbreak in West Africa, the EBOV probe described in the study will also detect that particular strain. The multiplex suspension bead array system developed can easily be adapted to emerging new strains by including additional beads. The study was published in the April 2015 issue of the Journal of Clinical Microbiology.

Related Links:

Public Health Agency of Sweden 
Invitrogen 
Bio-Rad Laboratories 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Immunofluorescence Analyzer
IFA System
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Mpox Analysis Reveals Substantial Suspected False Positives Associated with Contamination

Reliable confirmation of mpox can be difficult where multiple rash-causing illnesses co-circulate and laboratory capacity is limited. Although PCR is central to case detection, contamination during specimen... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.